Depressive symptoms and quality of life associated with the use of monoclonal antibodies in breast cancer treatment

Literals

vivo:identifier
- 2021-57
bibo:doi
- 10.1188/21.onf.535-545
dcterms:contributor
- Caceres M.C., Perez-Civantos D., Guerrero-Martin J., Delgado M.N., Jurado C.L., Duran-Gomez N.
ou:bibtex
- @article{PMID:34411080, title = {Depressive Symptoms and Quality of Life Associated With the Use of Monoclonal Antibodies in Breast Cancer Treatment.}, author = {Cáceres M and Pérez-Civantos D and Guerrero-Martín J and Delgado M and Jurado C and Durán-Gómez N}, doi = {10.1188/21.onf.535-545}, journal = {Oncology nursing forum}, month = {09}, year = {2021} }
dcterms:creator
- Cáceres M.C.
bibo:issn
- 0190-535X
ou:eid
- 2-s2.0-85114659949
dcterms:title
- Depressive symptoms and quality of life associated with the use of monoclonal antibodies in breast cancer treatment
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114659949&origin=inward
bibo:eissn
- 1538-0688
ou:urlOrcid
- http://europepmc.org/abstract/med/34411080
bibo:page_range
- 535-545
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114659949&origin=inward
fabio:hasPublicationYear
- 2021
dcterms:publisher
- Oncology Nursing Forum
ou:tipoPublicacion
- Article
ou:vecesCitado
- 3
bibo:volume
- 48